Some images has been designed using resources from Unsplash & Pixabay & Pexels & Freepik and some icons from Flaticon
跳到主要內容
全站搜尋
:::
▍發表論文
:::

2025年

  1. 1Chiang YL, Su GY, Tsai SC, Chen CN, Hwu CM, Wu TH. Wu TH*. Waist circumference is an important determinant of relative muscle strength in patients with type 2 diabetes mellitus. J. Chin. Med. Assoc. 2025;88(10):767-773. (IF:2.4)
  2. 2Chen HH*, Chen CH, Hou MC, Fu YC, Li LH, Chou CY, Yeh EC, Tsai MF, Chen CH, Yang HC, Huang YT, Liu YM, Wei CY, Su JP, Lin WJ, Wang EHF, Chiang CL, Jiang JK, Lee IH, Liang KH, Chen WS, Tsai HC, Lin SY, Chang FP, Ho HL, Yeh YC, Tseng WC, Lin MH, Chang HT, Tseng LM, Liang WY, Chen PCH, Hsieh YC, Chen YM, Hsiao TH, Lin CH, Chen YJ, Chen IC, Mao CL, Chang SJ, Chang YL, Liao YJ, Lai CH, Lee WJ, Tung H, Yen TT, Yen HC, Chen MY, Lin YC, Kao YT, Kao BZ, Lee JE, Chung CL, Liu JC, Chan P, Lin CH, Chen CH, Wu IC, Lin LC, Wang JW, Shih SL, Hsieh SW, Hung CH, Li WM, Yang CJ, Yang CS, Weng RH, Chen YC, Chang CP, Wu TH, Lin YC, Sheen YJ, Wang SH, Chen SP, Raben T, Widen E, Hsu S, Hsieh FJ, Ho DR, Huang YH, Yang CH, Huang YS, Chen YF, Wu HM, Tsai PH, Huang KG, Chien CY, Ho YL, Wu MS, Kao JH, Liu YB, Juang JMJ, Lin MH, Lin YH, Lee JY, Lu HJ, Lu CH, Feng AC, Liu JS, Chiang CP, Chu NF, Lin JC, Yeh YW, Meng E, Huang CY, Li CC, Wang TF, Su KY, Wang JK, Chen MH, Chen HF, Ma GC, Chang TY, Chiang FT, Chang HJ, Kao KJ, Hung CF, Tsai CY, Chen PY, Tsui K, Chen YT, Kwok PY, Sheu WHH, Yang SF, Liou JM, Wang JY, Chiou JF, Wu JY, Fann CSJ*. Population-specific polygenic risk scores for people of Han Chinese ancestry. Nature 2025;648(8092):128-137. (IF:48.5)
  3. 2Chen KL, Chou RH*, Chang CC, Kuo CS, Wei JH, Lu YW, Teng H, Huang PH*, Lin SJ. Sepsis-associated liver dysfunction confounds the association between circulating PCSK9 concentration and mortality in septic patients: A single-center retrospective cohort study. J. Crit. Care 2025;90:155197. (IF:2.9)
  4. 5Chen MH, Lin LY, Hung TY, Lin TC, Li CY, Lin TH, Chen YH, Liou JT, Wang MT*. Comparative cardiovascular risk of sulfonylureas with low- and high-affinities for cardiac mitochondrial adenosine triphosphate-sensitive potassium channels versus dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: A cohort study. Diabetes Obes. Metab. 2025;27(12):7502-7513. (IF:5.7)
  5. 5Chen YG, Wei JCC, Yen FS, Sung CY, Huang YH, Yu TS, Tsai FJ, Hwu CM*, Hsu CC*. Target trial emulation of DPP-4 Inhibitors in patients with T2DM for pulmonary tuberculosis: a nationwide observational data. BMC Med. 2025;23(1): 587. (IF:8.3)
  6. 1Cheng WY, Yen FS, Hung YM, Wei JCC, Lin HJ, Huang YH, Hsu CC, Hwu CM*. SGLT2 inhibitors for primary prevention of macrovascular and major microvascular complications in type 2 diabetes: an island-wide cohort study. J. R. Soc. Med. 2025;118(11):347-357. (IF:10.3)
  7. Hsu PWC, Chen YR, Sheu WHH*. MetS-Z: A gender- and age-specific scoring system for predicting type 2 diabetes. J. Diabetes Investig. 2025;16(5):907-916. (IF:3)
  8. Hsu PWC, Yeh CH, Lo CJ, Tsai TH, Chan YH, Chou YJ, Yang N, Cheng ML, Sheu WHH, Lai CC*, Sytwu HK*, Tsai TF*. Trans-omics analyses identify the biochemical network of LPCAT1 associated with coronary artery disease. Biomark. Res. 2025;13(1):107. (IF:11.5)
  9. 2Hung TY, Lin TC, Liou YJ, Lin TH, Hsu YJ, Lin LY*, Wang MT*. Use of dipeptidyl peptidase-4 inhibitors is associated with lower risk of severe renal outcomes in pre-dialysis patients with Type 2 diabetes. J. Intern. Med. 2025;298(3):214-227. (IF:9.2)
  10. 1Ko FS, Wu TH, Su GY, Lin YH, Juan CC, Hwu CM*. Blood Cell Count-Based Inflammatory Markers Exhibit Superior Association with Diabetic Peripheral Neuropathy Compared to Protein-Based Markers. J. Inflamm. Res. 2025;18():10609-10617. (IF:4.1)
  11. 1Lee CC, Ko FS, Yen FS*, Hwu CM*. LX9211, a rising star for relieving of diabetic peripheral neuropathic pain. J. Diabetes Investig. 2025;16(2):176-179. (IF:3)
  12. 1Lee PS, Chen JY, Kuo PC, Lee CC, Chen PL, Chen HS, Huang CJ*. Influence of Preoperative Thyroid Status on Clinical Outcomes in Graves' Disease Undergoing Thyroidectomy. World J.Surg. 2025;49(9):2464-2473. (IF:2.5)
  13. 1Lee PS, Chen JY, Lee CC, Pan LH, Hang JF, Kuo PC, Yao SF, Hwu CM*, Kuo CS*. Validation of preoperative BRAF V600E testing by ThyroSCAN PanelChip in thyroid nodules. Endocr. Connect. 2025;14(5):-. (IF:2.8)
  14. 1Liao TY, Lin YC, Huang CJ, Hwu CM, Lin LY*. Clinical efficacy and safety of fluconazole treatment in patients with Cushing's syndrome. Ther. Adv. Endocrinol. Metab. 2025;16:20420188251372275. (IF:4.6)
  15. 1Lin DC, Hou JY, Tseng CK, Tsai PS*. The changes in imaging following proton beam therapy for pediatric hepatoblastoma. Eur. J. Pediatr. 2025;184(10):626. (IF:2.6)
  16. 1Lin DC, Tsai PS, Lin TL, Huang WH, Liu YP, Wu TH, Shih CT*. Predicting complications and morbidities in PAD patients through lower extremity compositions with dual-energy CT and material decomposition: a 2-year follow-up observational study. BMC Cardiovasc. Disord. 2025;25(1):268. (IF:2.3)
  17. 2Lin LY*, Chang TT, Leu HB, Huang CC, Wu TC, Chou RH, Huang PH, Yin WH, Tseng WK, Wu YW, Lin TH, Yeh H, Chang KC, Wang JH, Wu CC, Chen JW*. Novel prognostic impact and cell specific role of endocan in patients with coronary artery disease. Clin. Res. Cardiol. 2025;114(8):952-968. (IF:3.7)
  18. 2Lin LY, Lin YH, Chueh SJ, Yeh CH, Wu CH, Cheng HM, Hwang SJ, Liu FH, Yang J, Wu VC*. Universal Screening for Primary Aldosteronism in Hypertensive Patients: A 2025 Taipei Positional Paper. J. Clin. Hypertens. 2025;27(9):e70102. (IF:2.5)
  19. 2Lin TH, Hung TY, Lin LY, Lin TC, Liou YJ, Hsu YJ, Wang MT*. Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus and End-Stage Renal Disease Requiring Dialysis. Pharmacoepidemiol. Drug Saf. 2025;34(4):e70138. (IF:2.4)
  20. 2Liu SY, Chen LK, Li PH, Wu GL, Wu TH, Yu YB*, Lin HF*, Juan CC*. Glucosamine induces hepatic FGF21 expression by activating the Akt/mTOR/p70S6K axis and driving PGC-1α activity. Sci Rep 2025;15(1):13096. (IF:3.9)
  21. 5Pan LH, Yeh CC, Yang SJ, Yang CC, Hwu CM, Chen HS, Wang FF, Huang CJ*. A Prospective Study to Determine Trimester-Specific Thyroid Function Reference Intervals. J. Endocrinol. Invest. 2025;48(10):2351-2360. (IF:3.5)
  22. 5Pan LH, Yeh CC, Yang SJ, Yang CC, Hwu CM, Chen HS, Wang FF, Huang CJ*. Iodine nutritional status in different trimesters of pregnancy and its association with dietary habits: a prospective observational study in Taiwan. BMC Pregnancy Childbirth 2025;25(1):323. (IF:2.7)
  23. 1Sheu WH*, Lee C-Y, Wang Y-, Liao C-, Hsiao T-, Suzuki K, Hatzikotoulas K, Morris AP, Chen YI, Rotter JI*. Glycaemic responses to metformin monotherapy by SNP clusters in patients with type 2 diabetes. Diabetes Obes. Metab. 2025;27(11):6323-6332. (IF:5.7)
  24. 5Smit RAJ, Wade KH, Hui Q, Arias JD, Yin XY, Christiansen MR, Yengo L, Preuss MH, Nakabuye M, Rocheleau G, Graham SE, Buchanan VL, Chittoor G, Graff M, Guindo-Martinez M, Lu YC, Marouli E, Sakaue S, Spracklen CN, Vedantam S, Wilson EP, Chen SH, Ferreira T, Ji YJ, Karaderi T, Lull K, Machado M, Malden DE, Medina-Gomez C, Moore A, Rueger S, Akiyama M, Allison MA, Alvarez M, Andersen MK, Appadurai V, Arbeeva L, Bartell E, Bhaskar S, Bielak LF, Bis JC, Bollepalli S, Bork-Jensen J, Bradfield JP, Bradford Y, Brandl C, Braund PS, Brody JA, Broeckel U, Burgdorf KS, Cade BE, Cai QY, Camarda S, Campbell A, Canadas-Garre M, Chai JF, Chesi A, Choi SH, Christofidou P, Couture C, Cuellar-Partida G, Danning R, Degenhardt F, Delgado GE, Delitala A, Demirkan A, Deng X, Dietl A, Dimitriou M, Dimitrov L, Dorajoo R, Eliasen AU, Engmann JE, Erdos MR, Fairhurst-Hunter Z, Farmaki AE, Faul JD, Fernandez-Lopez JC, Forer L, Frank M, Freitag-Wolf S, Fritsche LG, Fuchsberger C, Galesloot TE, Gao Y, Geller F, Giannakopoulou O, Giulianini F, Gjesing AP, Goel A, Gordon SD, Gorski M, Grove J, Guo XQ, Gustafsson S, Haessler J, Hansen TF, Havulinna AS, Haworth SJ, Heard-Costa N, Hemerich D, Highland HM, Hindy G, Ho YL, Hofer E, Holliday E, Horn K, Hornsby WE, Hottenga JJ, Huang HY, Huang J, Huerta-Chagoya A, Huo SF, Hwang MY, Hwu CM, Iha H, Ikeda DD, Isono M, Jackson AU, Jansen IE, Jiang YX, Johansson I, Jonsson A, Jorgensen T, Kalafati IP, Kanai M, Kanoni S, Karhus LL, Kasturiratne A, Katsuya T, Kawaguchi T, Kember RL, Kentistou KA, Kim D, Kim HN, Kim YJ, Kleber ME, Knol MJ, Kurbasic A, Lauzon M, Le P, Lea R, Lee JY, Lee WJ, Leonard HL, Li HT, Li SCA, Li XH, Li XY, Liang JJ, Lin HH, Lin K, Liu J, Liu XP, Lo KS, Long JR, Lores-Motta L, Luan JA, Lyssenko V, Lyytikainen LP, Mahajan A, Malik MZ, Mamakou V, Mangino M, Manichaikul A, Marten J, Mattheisen M, McDaid AF, Mei QS, Meiselbach H, Melendez TL, Milaneschi Y, Miller JE, Millwood IY, Mishra PP, Mitchell RE, Mollehave LT, Mononen N, Mucha S, Munz M, Mykkaenen J, Nakatochi M, Nardone GG, Nelson CP, Nethander M, Nho CW, Nielsen AA, Nolte IM, Nongmaithem SS, Noordam R, Ntalla I, Nutile T, Pandit A, Pauper M, Peters ERB, Peters LV, Piluso F, Polasek O, Poveda A, Pyarajan S, Raffield LM, Rakugi H, Ramirez J, Rasheed A, Raven D, Rayner NW, Riveros C, Rohde R, Ruggiero D, Ruotsalainen SE, Ryan KA, Sabater-Lleal M, Santin A, Saxena R, Scholz M, Shen BT, Shi JCZ, Shin JH, Sidore C, Sidorenko J, Sim X, Slieker RC, Smith AV, Smith JA, Smyth LJ, Southam L, Steinthorsdottir V, Sun L, Takeuchi F, Taylor KD, Tayo BO, Tcheandjieu C, Terzikhan N, Tesolin P, Teumer A, Theusch E, Thompson DJ, Thorleifsson G, Timmers PRHJ, Trompet S, Turman C, Vaccargiu S, van der Laan SW, van der Most PJ, van Klinken JB, van Setten J, Verma SS, Verweij N, Veturi Y, Wang CA, Wang CL, Wang JS, Wang LH, Wang YX, Wang Z, Warren HR, Wei WB, Wen WQ, Wheeler WA, Wickremasinghe AR, Wielscher M, Winsvold BS, Wong A, Wuttke M, Xia R, Yamamoto K, Yang JY, Yao J, Young H, Yousri NA, Yu L, Zeng LY, Zhang WH, Zhang XY, Zhao JH, Zhao W, Zhou W, Zimmermann ME, Zoledziewska M, 't Hart LM, Adair LS, Adams HHH, Aguilar-Salinas CA, Al-Mulla F, Arnett DK, Asselbergs FW, Asvold BO, Attia J, Banas B, Bandinelli S, Beilin LJ, Bennett DA, Bergler T, Bharadwaj D, Biino G, Boerwinkle E, Boeger CA, Borja JB, Bouchard C, Bowden DW, Brandslund I, Ben Brumpton, Buring JE, Caulfield MJ, Chambers JC, Chandak GR, Chanock SJ, Chaturvedi N, Chen YDI, Chen ZM, Cheng CY, Cho YS, Christensen K, Christophersen IE, Ciullo M, Cole JW, Collins FS, Concas MP, Cooper RS, Cruz M, Cucca F, Cutler MJ, Damrauer SM, Dantoft TM, de Borst GJ, de Geus. Polygenic prediction of body mass index and obesity through the life course and across ancestries. Nat. Med. 2025;31(9):3151-3168. (IF:50)
  25. Su YW, Sheu WHH, Hwu CM, Chen YC, Chen JF, Peng YS, Huang CN, Hung YJ, Chen HS*. Application of machine learning algorithms to identify risk factors for depression in type 2 diabetes mellitus patients: A Taiwan diabetes registry study. J. Chin. Med. Assoc. 2025;88(7):513-519. (IF:2.4)
  26. 1Sung JH, Ko FS, Wu TH, Tsai SC, Hwu CM*, Su GY*. Ratio of fat-free mass to fat mass is associated with physical performance in patients with type 2 diabetes mellitus. Front. Endocrinol. 2025;16:1562870. (IF:4.6)
  27. 5Tiwaskar M, Hwu CM*, Lim M, Bhandary A, Chang I. Treatment Preferences for Novel Type 2 Diabetes Oral Medications: Insights from the Asian Diabetes Patient Preference Study. Diabetes Ther. 2025;16(9):1841-1859. (IF:2.6)
  28. 5Wu IW, Liao YC, Tsai TH, Lin CH, Shen ZQ, Chan YH, Tu CW, Chou YJ, Lo CJ, Yeh CH, Chen CY, Pan HC, Hsu HJ, Lee CC, Cheng ML, Sheu WHH, Lai CC*, Sytwu HK*, Tsai TF*. Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease. Gut Microbes 2025;17(1):2473506. (IF:11)
  29. 2Wu YW, Chen JW, Lin LY, Huang JH, Chang CC, Chang TT*. FABP4 inhibition protects renal tubular cells and ameliorates renal inflammation in diabetic kidney disease. Biochem. Pharmacol. 2025;236:116899. (IF:5.6)
  30. 1Yang JH, Matthew-Duncan L, Laws H, Isles S, Shu YF, Lee Y, Lin LX, Kang SY, Hsu HW, Hwu CM, Chen HC*, Su GY*. The metabolic chronic disease prevention program in Saint Kitts and Nevis: a dietary recall study. Front. Nutr. 2025;12:1617389. (IF:5.1)
  31. 1Yang JH, Wang WH, Chen HS*. Evaluating pituitary tumor management: aligning with pituitary tumor centers of excellence criteria. Pituitary 2025;28(5):91. (IF:3.4)
  32. 1Yeh HY, Pan MH, Huang CJ, Hong SY, Yang H*, Yang YY, Huang CC, Tsai HC, Li TH, Su CW, Hou MC. Triglyceride-glucose index and cancer risk: a prospective cohort study in Taiwan. Diabetol. Metab. Syndr. 2025;17(1):283. (IF:3.9)
  33. 1Yeh HY, Shih ML, Chang JW, Lin LY, Kao ZK, Hsieh AR, Tsai PH, Wang JT*, Chen YC*. Voluntary vitamin D testing: a decade-long study of utilisation patterns and impact on deficiency outcomes in Taiwan. Public Health Nutr. 2025;28(1):e171. (IF:3)
  34. 5Yen FS*, Wang SW, Hung YM, Hsu CC, Hwu CM*, Wei JC-C*. Impact of glucagon-like peptide-1 receptor agonists on the incidence of inflammatory bowel disease in people with type 2 diabetes. Diabetes Obes. Metab. 2025;27(11):6403-6415. (IF:5.7)
  35. 5Yen FS, Hou MC, Wei JCC, Huang YH, Shih YH, Pan CW, Wang ST, Hwu CM*, Hsu CC*. Sodium-Glucose Cotransporter 2 Inhibitors Use in Patients With Liver Cirrhosis. Diabetes-Metab. Res. Rev. 2025;41(5):e70070. (IF:6)
  36. 5Yen FS, Hsu CC, Yeh YK, Cheng WY, Liao PL, Hwu CM*, Wei JCC*. The impact of sodium-glucose cotransporter-2 inhibitors on dialysis risk and mortality in kidney transplant patients with diabetes. Am. J. Transplant. 2025;25(9):1954-1964. (IF:8.2)
  37. 5Yen FS, Huang JY, Dong C, Hwu CM, Hsu CC*, Wei JCC*. Impact of SGLT2 inhibitors on kidney health and survival in patients with polycystic kidney disease and type 2 diabetes. Diabetes Res. Clin. Pract. 2025;226:112357. (IF:7.4)
  38. 5Yen FS, Hung YM, Huang JY, Hsu CC, Cheng WY, Hwu CM*, Wei JCC*. Effects of SGLT2 inhibitors on transplant survival and key clinical outcomes in heart transplant recipients with diabetes. J. Intern. Med. 2025;297(5):532-542. (IF:9.2)
  39. 5Yen FS, Wang SI, Hwu CM, Haung CW, Chang RN, Hsu CC*, Wei JCC*. Comparative risk of rheumatoid arthritis between glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors in type 2 diabetes. J. Autoimmun. 2025;157:103493. (IF:7)
  40. 5Yen FS, Wei JCC, Cheng WY, Huang CT, Wu YL, Teh SH, Hwu CM, Hsu CC*. Low birth weight and chronic kidney disease with progression to kidney failure in children. Nephrol. Dial. Transplant. 2025;40(8):1550-1558. (IF:5.6)
  41. 5Yen FS, Wei JCC, Huang YH, Hsu TJ, Wang ST, Hwu CM*, Hsu CC*. SGLT-2 Inhibitors and the Risk of Chronic Obstructive Pulmonary Disease Exacerbations and Mortality in Chronic Obstructive Pulmonary Disease Patients. Ann. Am. Thoracic Society 2025;22(6):846-854. (IF:5.4)
  42. 5Yen FS, Wei JCC, Huang YH, Li PY, Tsai FJ, Hsu CC*, Hwu CM*. Comparative outcomes of adding SGLT2 inhibitors versus incretin-based therapies to insulin in type 2 diabetes. Diabetes Res. Clin. Pract. 2025;226:112328. (IF:7.4)
  43. 5Yen FS, Wei JCC, Hung YM, Li PY, Hsu CC*, Hwu CM*. SGLT2 Inhibitors and Prevention of Cardiovascular Events in Diabetes Patients with and Without Hypertension: A Nationwide Cohort Study. J. Gen. Intern. Med. 2025. (IF:4.2)
  44. 5Yen FS, Wei JCC, Hung YM, Liu JS, Hwu CM*, Hsu CC*. Income and wealth inequality is associated with young-onset type 2 diabetes. World J. Diabetes 2025;16(9):108480. (IF:4.6)
  45. 5Yen FS, Wei JCC, Ko FS, Huang YH, Yip HT, Tsai FJ, Hwu CM*. Association of DPP-4 inhibitors with respiratory and cardiovascular complications in patients with COPD: a nationwide cohort study. ERJ Open Res. 2025;11(3):00919-2024. (IF:4)
  46. 5Yen FS, Wei JCC, Lin SY, Hsu JF, Yeh YK, Huang YH, Hsu TJ, Cho DY, Hwu CM*, Hsu CC*. The Impact of Pay-for-Performance Care on the Mortality and Cardiovascular Outcomes in Older Adults with Newly Diagnosed Type 2 Diabetes: A Nationwide Population-Based Cohort Study. J. Am. Med. Dir. Assoc. 2025;26(2):105382. (IF:3.8)
  47. 5Yen FS, Wei JCC, Lu WY, Yen YH, Wu YL, Lo YR, Hwu CM*, Hsu CC*. Income-related inequities in the progression from gestational to type 2 diabetes: Findings from Taiwan's maternal and child health database. Diabetes Obes. Metab. 2025. (IF:5.7)
  48. 5Yen FS, Wei JCC, Sung CY, Li PY, Tsai FJ, Hsu CC*, Hwu CM*. Impact of Adding GLP-1 Receptor Agonists to Insulin Therapy on Cardiovascular and Microvascular Outcomes in Type 2 Diabetes: A Nationwide Cohort Study from Taiwan. Pharmaceuticals 2025;18(9). (IF:4.8)
  49. 5Yen FS, Wei JCC, Wang C, Hou MC, Yu TS, Huang YH, Hwu CM*, Hsu CC*. Sodium-Glucose Cotransporter2 inhibitors and associated Liver-Related outcomes in diabetes patients. Diabetes Res. Clin. Pract. 2025;223:112174. (IF:7.4)
  50. 5Yen FS, Wei JCC, Wu YL, Lo YR, Chen CM, Hwu CM, Hsu CC*. Impact of family income on the development of gestational diabetes mellitus and the associated birth outcomes: A nationwide study. J. Diabetes Investig. 2025;16(1):51-59. (IF:3)
  51. 5Yen FS, Yen YH, Hung YM, Wei JCC, Tsai FJ, Hung YT, Lin HJ, Hwu CM*, Hsu CC*. Diabetic Microvascular Disease and Risk of Peripheral Artery Disease, Foot Ulcer, Leg Infection, and Amputation. Thromb. Haemost. 2025. (IF:4.3)
  52. 5Yen HY, Lin YH, Wang YF, Fuh JL, Wang SJ, Chen HS, Chiang SC, Li SR, Lin MH, Chen TJ, Hwang SJ, Chang HT*. The association between metabolic syndrome components and cognitive function in community-dwelling middle-aged and older adults: the first wave result of a cohort study. J. Heatlh Popul. Nutr. 2025;44(1):94. (IF:2.8)
  53. 5Yen YH, Wei JCC, Yen FS, Kao YS, Lin HJ, Cho DY, Hwu CM*, Hsu CC*. Microvascular Complications and Cancer Risk in Type 2 Diabetes: A Population-Based Study. Cancers 2025;17(11):1760. (IF:4.4)
  54. 5Yueh MP, Kao SK, Chen JW, Huang JC, Chen HS, Wu TE*. Psoriasis and risk of diabetic retinopathy in patients with type 2 diabetes mellitus. Diabetes Res. Clin. Pract. 2025;229:112912. (IF:7.4)
  55. 5Zhang XR*, Brody JA, Graff M, Highland HM, Chami N, Xu HFF, Wang Z, Ferrier KR, Chittoor G, Josyula NS, Meyer M, Gupta S, Li XH, Li ZL, Allison MA, Becker DM, Bielak LF, Bis JC, Boorgula MP, Bowden DW, Broome JG, Buth EJ, Carlson CS, Chang KM, Chavan S, Chiu YF, Chuang LM, Conomos MP, Demeo DL, Du MM, Duggirala R, Eng C, Fohner AE, Freedman BI, Garrett ME, Guo XQ, Haiman C, Heavner BD, Hidalgo B, Hixson JE, Ho YL, Hobbs BD, Hu DL, Hui Q, Hwu CM, Jackson RD, Jain D, Kalyani RR, Kardia SLR, Kelly TN, Lange EM, Lenoir M, Li CW, Le Marchand L, Mcdonald MLN, Mchugh CP, Morrison AC, Naseri T, O'Connell J, O'Donnell CJ, Palmer ND, Pankow JS, Peters U, Preuss MH, Rao DC, Regan EA, Reupena SM, Roden DM, Rodriguez-Santana J, Sitlani CM, Smith JA, Tiwari HK, Vasan RS, Wang ZY, Weeks DE, Wessel J, Wiggins KL, Wilkens LR, Wilson PWF, Yanek LR, Yoneda ZT, Zhao W, Zollner S, Arnett DK, Ashley-Koch AE, Barnes KC, Blangero J, Boerwinkle E, Burchard EG, Carson AP, Chasman DI, Chen YDI, Curran JE, Fornage M, Gordeuk VR, He J, Heckbert SR, Hou LF, Irvin MR, Kooperberg C, Minster RL, Mitchell BD, Nouraie M, Psaty BM, Raffield LM, Reiner AP, Rich SS, Rotter JI, Shoemaker MB, Smith NL, Taylor KD, Telen MJ, Weiss ST, Zhang YZ, Heard-Costa N, Sun YV, Lin XH, Cupples LA, Lange LA, Liu CT, Loos RJF, North KE, Justice AE*. Whole genome sequencing analysis of body mass index identifies novel African ancestry-specific risk allele. Nat. Commun. 2025;16(1):3470. (IF:15.7)

最後更新：

回到最上